Medigen Biotechnology Corp. (3176.TWO)
TWD 29.4
(1.03%)
TWD 29.4
(1.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.23 Billion TWD | 26.03% |
| 2022 | -1.66 Billion TWD | -311.22% |
| 2021 | 789.2 Million TWD | 186.52% |
| 2020 | -912.17 Million TWD | -19.66% |
| 2019 | -762.32 Million TWD | 0.01% |
| 2018 | -762.41 Million TWD | -17.93% |
| 2017 | -646.52 Million TWD | 13.84% |
| 2016 | -750.33 Million TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -27.84 Million TWD | 80.01% |
| 2024 Q1 | -139.34 Million TWD | 74.86% |
| 2023 Q3 | -85.64 Million TWD | 75.62% |
| 2023 FY | -1.23 Billion TWD | 26.03% |
| 2023 Q1 | -241.84 Million TWD | 67.36% |
| 2023 Q4 | -554.29 Million TWD | -547.2% |
| 2023 Q2 | -351.31 Million TWD | -45.26% |
| 2022 Q1 | -182.3 Million TWD | -118.64% |
| 2022 FY | -1.66 Billion TWD | -311.22% |
| 2022 Q4 | -740.89 Million TWD | -88.38% |
| 2022 Q3 | -393.3 Million TWD | -12.22% |
| 2022 Q2 | -350.47 Million TWD | -92.25% |
| 2021 Q3 | 579.47 Million TWD | 0.0% |
| 2021 FY | 789.2 Million TWD | 186.52% |
| 2021 Q4 | 978.1 Million TWD | 68.79% |
| 2020 FY | -912.17 Million TWD | -19.66% |
| 2019 FY | -762.32 Million TWD | 0.01% |
| 2018 FY | -762.41 Million TWD | -17.93% |
| 2017 FY | -646.52 Million TWD | 13.84% |
| 2016 FY | -750.33 Million TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 537.498% |
| Level Biotechnology Inc. | 67.55 Million TWD | 1925.398% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | -1351.654% |
| GlycoNex Incorporation | -259.86 Million TWD | -374.515% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | -437.799% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | -54631.158% |
| Visgeneer Inc. | -21.15 Million TWD | -5727.747% |
| Mycenax Biotech Inc. | -602.1 Million TWD | -104.798% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 1628.299% |
| Neith Corporation | -48.85 Million TWD | -2424.037% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 2046.938% |
| Lin BioScience, Inc. | -1.09 Billion TWD | -12.424% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 5203.439% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | -1647.036% |
| Lukas Biomedical Inc. | -43.56 Million TWD | -2730.792% |
| BiOptic Inc. | 44.05 Million TWD | 2899.112% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | -77.647% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 469.099% |
| Sagittarius Life Science Corp | -64.37 Million TWD | -1815.455% |
| TaiMed Biologics Inc. | -166.23 Million TWD | -641.795% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | -1221.133% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 237.807% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | -1.587% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | -18554.962% |
| Enimmune corporation | -243.47 Million TWD | -406.456% |
| TaiRx, Inc. | -214.69 Million TWD | -474.346% |
| CHO Pharma, Inc. | -268.99 Million TWD | -358.402% |
| EirGenix Inc. | -1.03 Billion TWD | -19.488% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | -1610.349% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | -598.474% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | -1867.189% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | -1773.432% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | -2609.975% |
| VBI | -16.13 Million TWD | -7543.77% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | -1350.8% |
| RBC Bioscience Corporation | 14.53 Million TWD | 8581.278% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | -2072.889% |
| NaviFUS Corp. | -76.42 Million TWD | -1513.447% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | -1212.429% |
| Sinew Pharma Inc. | -186.25 Million TWD | -562.053% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | -1721.488% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 871.566% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | -228.278% |
| AP Biosciences Inc | -347.47 Million TWD | -254.869% |
| 3D Global Biotech Inc. | -62.85 Million TWD | -1861.868% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | -43564.766% |
| Intech Biopharm Corporation | -304.39 Million TWD | -305.095% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | -12.444% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | -2872.598% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | -627.248% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 465.11% |
| TCI GENE Inc. | 10.04 Million TWD | 12370.803% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | -868.979% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | -296.351% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | -481.088% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | 36008.358% |
| PharmaEngine, Inc. | 277.18 Million TWD | 544.866% |
| Savior Lifetec Corporation | -2.42 Million TWD | -50854.256% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | -605.839% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 40.994% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | -901.261% |
| Acepodia, Inc. | -435.97 Million TWD | -182.836% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | -152.705% |